Regeneron Pharmaceuticals Inc (NASDAQ:REGN) - Share price


Stock Report

Regeneron Pharmaceuticals Inc REGN

Margins (% of Sales)
20142015201620172018
Revenue100.00%100.00%100.00%100.00%100.00%
Cost of Revenue7.27%9.57%6.17%6.76%6.47%
Gross Margin92.73%90.43%93.83%93.24%93.53%
SG&A17.90%20.43%24.23%22.49%23.19%
Research and development45.09%39.49%42.22%35.34%32.58%
Operating Margin29.74%30.51%27.38%35.41%37.77%
Net Int, Inc and Other57.25%60.36%54.74%70.81%75.82%
EBT Margin27.51%29.85%27.36%35.40%38.05%
Profitability
20142015201620172018
Tax Rate15.17%14.35%8.94%14.99%1.63%
Net Margin12.34%15.50%18.42%20.41%36.42%
Return on Assets10.2013.4214.2315.2323.85
Financial Leverage1.521.531.571.431.34
Return on Equity15.4920.5322.1022.6332.81
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.